CORCEPT THERAPEUTICS INC Accretion Expense
CORCEPT THERAPEUTICS INC (CORT) reported Accretion Expense of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2019-02-26
- CORCEPT THERAPEUTICS INC accretion expense for the quarter ending 2018-12-31 was $0.00.
- CORCEPT THERAPEUTICS INC accretion expense for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- CORCEPT THERAPEUTICS INC accretion expense for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- CORCEPT THERAPEUTICS INC accretion expense for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- CORCEPT THERAPEUTICS INC accretion expense for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- CORCEPT THERAPEUTICS INC accretion expense for fiscal 2017 was $500.00K, a 74.08% decline from fiscal 2016.
- CORCEPT THERAPEUTICS INC accretion expense for fiscal 2016 was $1.93M, a 32.27% decline from fiscal 2015.
- CORCEPT THERAPEUTICS INC accretion expense for fiscal 2015 was $2.85M, a 22.57% decline from fiscal 2014.
| Period end | Accretion Expense 3 month | Accretion Expense 3 month as first filed | Accretion Expense 6 month | Accretion Expense 6 month as first filed | Accretion Expense 9 month | Accretion Expense 9 month as first filed | Accretion Expense 12 month | Accretion Expense 12 month as first filed | Accretion Expense 32 month | Accretion Expense 35 month | Accretion Expense 38 month | Accretion Expense 44 month | Accretion Expense 47 month | Accretion Expense 50 month | Accretion Expense 53 month | Accretion Expense 56 month | Accretion Expense 59 month | Accretion Expense 60 month | Accretion Expense 62 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 derived: sum of 3 quarters · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 | |||||||||||||||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-02 | $0.00 derived: sum of 2 quarters · filed 2018-11-02 | $0.00 10-Q · filed 2018-11-02 | $0.00 derived: sum of 4 quarters · filed 2019-02-26 | |||||||||||||||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | $0.00 derived: sum of 3 quarters · filed 2019-02-26 | $37.00K derived: sum of 4 quarters · filed 2019-02-26 | |||||||||||||||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $37.00K derived: sum of 3 quarters · filed 2019-02-26 | $137.00K derived: sum of 4 quarters · filed 2019-02-26 | |||||||||||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $37.00K derived: sum of 2 quarters · filed 2019-02-26 | $137.00K derived: sum of 3 quarters · filed 2019-02-26 | $500.00K 10-K · filed 2019-02-26 | $456.00K 10-K · filed 2018-02-28 | ||||||||||||||
| 2017-09-30 | $37.00K 10-Q · filed 2018-11-02 | $137.00K derived: sum of 2 quarters · filed 2018-11-02 | $500.00K 10-Q · filed 2018-11-02 | $456.00K 10-Q · filed 2017-11-03 | $804.00K derived: sum of 4 quarters · filed 2018-11-02 | $15.00M 10-Q · filed 2017-11-03 | |||||||||||||
| 2017-07-31 | $15.00M 10-K · filed 2019-02-26 | ||||||||||||||||||
| 2017-06-30 | $100.00K 10-Q · filed 2018-08-09 | $149.00K 10-Q · filed 2017-08-02 | $400.00K 10-Q · filed 2018-08-09 | $419.00K 10-Q · filed 2017-08-02 | $767.00K derived: sum of 3 quarters · filed 2018-08-09 | $1.22M derived: sum of 4 quarters · filed 2018-08-09 | $15.00M 10-Q · filed 2017-08-02 | ||||||||||||
| 2017-03-31 | $300.00K 10-Q · filed 2018-05-09 | $270.00K 10-Q · filed 2017-05-02 | $667.00K derived: sum of 2 quarters · filed 2018-05-09 | $1.12M derived: sum of 3 quarters · filed 2018-05-09 | $1.65M derived: sum of 4 quarters · filed 2018-05-09 | $14.80M 10-Q · filed 2017-05-02 | |||||||||||||
| 2016-12-31 | $367.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $822.00K derived: sum of 2 quarters · filed 2018-02-28 | $1.34M derived: sum of 3 quarters · filed 2018-02-28 | $1.93M 10-K · filed 2018-02-28 | $14.50M 10-K · filed 2017-03-06 | ||||||||||||||
| 2016-09-30 | $455.00K 10-Q · filed 2017-11-03 | $978.00K derived: sum of 2 quarters · filed 2017-11-03 | $1.56M 10-Q · filed 2017-11-03 | $2.21M derived: sum of 4 quarters · filed 2018-02-28 | $14.20M 10-Q · filed 2016-11-02 | ||||||||||||||
| 2016-06-30 | $523.00K 10-Q · filed 2017-08-02 | $1.11M 10-Q · filed 2017-08-02 | $1.76M derived: sum of 3 quarters · filed 2018-02-28 | $2.46M derived: sum of 4 quarters · filed 2018-02-28 | $13.70M 10-Q · filed 2016-08-03 | ||||||||||||||
| 2016-03-31 | $584.00K 10-Q · filed 2017-05-02 | $1.24M derived: sum of 2 quarters · filed 2018-02-28 | $1.93M derived: sum of 3 quarters · filed 2018-02-28 | $2.67M derived: sum of 4 quarters · filed 2018-02-28 | $13.20M 10-Q · filed 2016-05-04 | ||||||||||||||
| 2015-12-31 | $652.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $1.35M derived: sum of 2 quarters · filed 2018-02-28 | $2.09M derived: sum of 3 quarters · filed 2018-02-28 | $2.85M 10-K · filed 2018-02-28 | |||||||||||||||
| 2015-09-30 | $698.00K 10-Q · filed 2016-11-02 | $1.44M derived: sum of 2 quarters · filed 2016-11-02 | $2.20M 10-Q · filed 2016-11-02 | $3.00M derived: sum of 4 quarters · filed 2017-03-06 | $12.00M 10-Q · filed 2015-11-06 | ||||||||||||||
| 2015-06-30 | $737.00K 10-Q · filed 2016-08-03 | $1.50M 10-Q · filed 2016-08-03 | $2.30M derived: sum of 3 quarters · filed 2017-03-06 | $3.20M derived: sum of 4 quarters · filed 2017-03-06 | $11.30M 10-Q · filed 2015-08-07 | ||||||||||||||
| 2015-03-31 | $762.00K 10-Q · filed 2016-05-04 | $1.57M derived: sum of 2 quarters · filed 2017-03-06 | $2.46M derived: sum of 3 quarters · filed 2017-03-06 | $3.40M derived: sum of 4 quarters · filed 2017-03-06 | $10.50M 10-Q · filed 2015-05-08 | ||||||||||||||
| 2014-12-31 | $804.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $1.70M derived: sum of 2 quarters · filed 2017-03-06 | $2.63M derived: sum of 3 quarters · filed 2017-03-06 | $3.68M 10-K · filed 2017-03-06 | |||||||||||||||
| 2014-09-30 | $895.00K 10-Q · filed 2015-11-06 | $1.83M derived: sum of 2 quarters · filed 2015-11-06 | $2.87M 10-Q · filed 2015-11-06 | $3.94M derived: sum of 4 quarters · filed 2016-03-10 | |||||||||||||||
| 2014-06-30 | $935.00K 10-Q · filed 2015-08-07 | $1.98M 10-Q · filed 2015-08-07 | $3.05M derived: sum of 3 quarters · filed 2016-03-10 | $4.15M derived: sum of 4 quarters · filed 2016-03-10 | |||||||||||||||
| 2014-03-31 | $1.04M 10-Q · filed 2015-05-08 | $2.11M derived: sum of 2 quarters · filed 2016-03-10 | $3.21M derived: sum of 3 quarters · filed 2016-03-10 | $4.31M derived: sum of 4 quarters · filed 2016-03-10 | |||||||||||||||
| 2013-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $2.17M derived: sum of 2 quarters · filed 2016-03-10 | $3.27M derived: sum of 3 quarters · filed 2016-03-10 | $4.41M 10-K · filed 2016-03-10 | |||||||||||||||
| 2013-09-30 | $1.10M 10-Q · filed 2014-11-07 | $2.20M derived: sum of 2 quarters · filed 2014-11-07 | $3.34M 10-Q · filed 2014-11-07 | $4.42M derived: sum of 4 quarters · filed 2015-03-13 | |||||||||||||||
| 2013-06-30 | $1.10M 10-Q · filed 2014-08-08 | $2.21M 10-Q · filed 2014-08-08 | $3.32M derived: sum of 3 quarters · filed 2015-03-13 | ||||||||||||||||
| 2013-03-31 | $1.11M 10-Q · filed 2014-05-12 | $2.22M derived: sum of 2 quarters · filed 2015-03-13 | |||||||||||||||||
| 2012-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.68M 10-K · filed 2015-03-13 | |||||||||||||||||
| 2012-09-30 | $575.00K 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |